Patent Application Titled "Aptamers For Personal Health Care Applications" Published Online (USPTO 20240209375).

The patent application titled "Aptamers For Personal Health Care Applications" discusses the development of aptamer compositions for preventing the binding of human rhinoviruses, which cause the common cold, to intercellular adhesion molecule 1 (ICAM-1). The inventors propose a composition of oligonucleotides that selectively bind to ICAM-1 and reduce the binding of human rhinoviruses, potentially mitigating symptoms or preventing reinfection. The compositions can be attached to active ingredients such as respiratory illness treatment agents, antiviral agents, and natural extracts, and a method for delivering the composition to the upper respiratory tract is also described. This patent application explores the potential use of aptamers for personal health care applications. [Extracted from the article]